A Study to Assess Single and Multiple Doses of IkT-148009 in Healthy Elderly Participants and Parkinson's Patients

Clinical trial NCT04350177 · COMPLETED

Trial details

NCT number: NCT04350177
Sponsor: ABLi Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Elderly Parkinson Disease

Start date: 2021-02-16
Primary completion: 2022-10-30
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.